Tasse Daniel Insider Trades

Insider Trading History

Track insider trading activity for Tasse Daniel. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regenxbio
Regenxbio RGNX
Director
Holding Value $573k 46,600 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 56,407 shares
$7.01
$12.29
DBV Technologies
DBV Technologies DBVT
CHIEF EXECUTIVE OFFICER
Holding Value $15.3M 964,000 shares
Last Trade
Nov 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3M 964,000 shares
$13.75
$15.92
Regenxbio
Regenxbio RGNX
Director
Holding Value $489k 39,815 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$352k 39,815 shares
$8.85
$12.29
DBV Technologies
DBV Technologies DBVT
CHIEF EXECUTIVE OFFICER
Holding Value $12.9M 813,200 shares
Last Trade
Dec 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.33M 813,200 shares
$4.10
$15.92
Regenxbio
Regenxbio RGNX
Director
Holding Value $301k 24,454 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$351k 24,454 shares
$14.35
$12.29
DBV Technologies
DBV Technologies DBVT
CHIEF EXECUTIVE OFFICER
Holding Value $272k 17,094 shares
Last Trade
Mar 08, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$147k 17,094 shares
$8.58
$15.92
DBV Technologies
DBV Technologies DBVT
Chief Executive Officer
Holding Value $12.8M 806,672 shares
Last Trade
Nov 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.86M 806,672 shares
$8.51
$15.92
Regenxbio
Regenxbio RGNX
Director
Holding Value $220k 17,892 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 17,892 shares
$19.72
$12.29
DBV Technologies
DBV Technologies DBVT
Chief Executive Officer
Holding Value $12.2M 764,386 shares
Last Trade
Nov 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2M 764,386 shares
$13.30
$15.92
Regenxbio
Regenxbio RGNX
Director
Holding Value $188k 15,324 shares
Last Trade
Jun 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 15,324 shares
$22.84
$12.29
DBV Technologies
DBV Technologies DBVT
Chief Executive Officer
Holding Value $4.36M 274,000 shares
Last Trade
Nov 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.06M 274,000 shares
$29.40
$15.92
Regenxbio
Regenxbio RGNX
Holding Value $123k 10,000 shares
Last Trade
Jun 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 10,000 shares
$35.52
$12.29
DBV Technologies
DBV Technologies DBVT
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2021 Sale
$20.3M 774,000 shares
$26.20
$15.92
Regenxbio
Regenxbio RGNX
Holding Value $123k 10,000 shares
Last Trade
May 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$377k 10,000 shares
$37.66
$12.29
Regenxbio
Regenxbio RGNX
Holding Value $123k 10,000 shares
Last Trade
May 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 10,000 shares
$43.02
$12.29
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Director
Holding Value $2.19k 182,604 shares
Last Trade
Jun 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$525k 11,987 shares
$43.80
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Director
Holding Value $699 58,216 shares
Last Trade
Jun 05, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 38,216 shares
$34.05
$0.01
Regenxbio
Regenxbio RGNX
Holding Value $154k 12,500 shares
Last Trade
May 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$618k 12,500 shares
$49.45
$12.29
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Director
Holding Value $120 10,000 shares
Last Trade
Sep 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$168k 10,000 shares
$16.80
$0.01
Bellerophon Therapeutics
Bellerophon Therapeutics BLPH
Director
Holding Value $2.05k 170,617 shares
Last Trade
Jun 28, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$525k 25,363 shares
$20.70
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up